MEDINDIA
English
हिन्दी
Español
français
中文
Tablets in the strengths of 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg were launched following approval from the US Food & Drug Administration.
Dr Reddy�s Laboratories Launch Tablets For Treatment Of Dementia In The US Market
Memantine hydrochloride tablets in the strengths of 5 mg and 10 mg are launched after getting the approval from the US Food and Drug Administration.
Memantine hydrochloride tablets in the strengths of 5 mg and 10 mg are launched after getting the approval from the US Food and Drug Administration.
The DRL product is available in bottle count sizes of 30, it added.
Source-PTI
Chest Pain Drug Withdrawn by Dr. Reddy�s Laboratories From US Market
Dr Reddy's volunteered to withdraw 13,560 bottles of metoprolol succinate tablets from the United States following the failure of dissolution tests, said the US Food and Drug Administration.
Dr Reddy's volunteered to withdraw 13,560 bottles of metoprolol succinate tablets from the United States following the failure of dissolution tests, said the US Food and Drug Administration.
Indian Pharmaceutical Company Recalls Anti-seizure and Hypertension Drugs from US Market
Hyderabad-based Dr Reddy’s Laboratories recalled the drugs as the tablets failed dissolution test and some are close to expiry date.
Hyderabad-based Dr Reddy’s Laboratories recalled the drugs as the tablets failed dissolution test and some are close to expiry date.
Dr. Reddy's Laboratories Net Profit Up by 14% in the First Quarter of 2015-16
Total income of the company has increased from Rs. 3,536.02 crore for the quarter ended June 30, 2014 to Rs. 3,770.25 crore for the quarter ended June 30, 2015.
Total income of the company has increased from Rs. 3,536.02 crore for the quarter ended June 30, 2014 to Rs. 3,770.25 crore for the quarter ended June 30, 2015.
Email
